GM EMEA | Global Head of Strategy & Growth | ex-Novartis
Ascentium Talent
Basel, Switzerland
4 profile visits
20+ years at the intersection of life sciences, data, and human performance. I've built organisations, platforms, and commercial systems from scratch — most recently bringing an AI Avatar platform to Europe and running it end to end.
We combine artificial intelligence with evidence-based talent science to pioneer the end-to-end quantification of the Training → Competency → Behavior → Business Results value chain. Our approach integrates real human interactions — how representatives, managers, and HCPs communicate — with rigorous learning science and precise engineering. Our multidisciplinary teams, operating across languages and markets, begin with a deep understanding of context and constraints, then apply measurement-driven methods to deliver durable behavior change. Quality underpins our work: structured evaluation rubrics, expert reviews, responsible deployment practices, clearly defined scopes, audit-ready operations, and rapid feedback loops. We design globally and localize thoughtfully. Diversity sharpens judgment; simplicity drives adoption. The result is defensible outcomes and solutions teams actually use.
I lead European strategy and commercial operations at Ascentium Talent GmbH, a Swiss AI company (Zug) delivering AI Avatar-based behavioural training for pharmaceutical sales teams. Our platform is deployed across 9 of the Top 10 global pharma companies, with 40+ enterprise deployments validated through peer-reviewed research.
My background spans pharma, life sciences tech, and digital transformation: Global Director for Future Field Engagement at Novartis (Basel), VP at Aktana (AI-guided selling, EMEA), CRM Solution Architect at Veeva Systems, and Head of Technology & Data at BASE Life Science (Copenhagen). Earlier career includes Deloitte, eBay, and UBS.
At Ascentium Talent, I am building the EMEA commercial and R&D engine from Switzerland — with active funding and grant developments, ISO 27001 certification in progress, and a seed funding round underway. I operate at the intersection of AI innovation, pharma commercial excellence, and Swiss regulatory standards.
I speak English, French, German, Dutch, and Spanish — and I'm here to connect with the people building what's next in life sciences innovation.
Seeking pharma commercial partners (Medical Affairs, Sales Excellence, L&D) and EMEA distribution partners (consultancies, CROs, training providers) to co-develop and scale AI Avatar-based HCP engagement simulation across European markets.
Offering expertise in conversational AI simulation for pharma rep development: HCP engagement practice, behavioural competency scoring, SOLO®-based learning outcome measurement, and EU AI Act deployment architecture. Live across 9 of Top 10 global pharma